116 results on '"Régnier, Catherine"'
Search Results
2. Impaired Neural Tube Closure, Axial Skeleton Malformations, and Tracheal Ring Disruption in TRAF4-Deficient Mice
3. Tumor Necrosis Factor (TNF)-Mediated Kinase Cascades: Bifurcation of Nuclear Factor-κ B and c-Jun N-Terminal Kinase (JNK/SAPK) Pathways at TNF Receptor-Associated Factor 2
4. Supplementary Table S2 from Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent
5. Data from Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent
6. Supplementary Figures, Methods, and References from Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent
7. Supplementary Data from Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805
8. The impact of lower limb chronic venous disease on quality of life: patient and physician perspectives
9. Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome
10. The prevalence, disease characteristics and treatment of chronic venous disease: an international web-based survey
11. The prevalence, characteristics and treatment of hemorrhoidal disease: results of an international web-based survey
12. Metastatic Lymph Node 51, a novel nucleo-cytoplasmic protein overexpressed in breast cancer
13. Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing
14. Optimization of the In Vivo Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood
15. Stabilizing Inactive Conformations of MALT1 as an Effective Approach to Inhibit Its Protease Activity
16. Requirement of Mucosa‐Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Protease Activity for Fcγ Receptor–Induced Arthritis, but Not Fcγ Receptor–Mediated Platelet Elimination, in Mice
17. Lasp-1, a Novel Type of Actin-Binding Protein Accumulating in Cell Membrane Extensions
18. Ephemeral fairies.
19. Characterization of immune functions in TRAF4-deficient mice
20. Stromelysin-3 in the biology of the normal and neoplastic mammary gland
21. N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity
22. The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition
23. Optimization of the In VivoPotency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood
24. Discovery of Potent, Highly Selective, and In VivoEfficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing
25. Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation
26. The T‐cell fingerprint of MALT1 paracaspase revealed by selective inhibition.
27. L'évaluation des structures expérimentales innovantes
28. The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling
29. Deficiency of MALT1 Paracaspase Activity Results in Unbalanced Regulatory and Effector T and B Cell Responses Leading to Multiorgan Inflammation
30. L’évaluation des structures expérimentales innovantes
31. Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors
32. 2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors
33. Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer
34. Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent
35. Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition
36. Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805
37. Hereditary complement C7 deficiency in nine families: Subtotal C7 deficiency revisited
38. L’évaluation des structures expérimentales innovantes
39. Transcription Regulation and Protein Subcellular Localization of the Truncated Basic Hair Keratin hHb1-ΔN in Human Breast Cancer Cells
40. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of Nuclear Factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2
41. Identification and Characterization of an IκB Kinase
42. MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is over-expressed in human breast carcinomas
43. Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains
44. Comparative expression of thepsoriasin (S100A7) andS100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22
45. Presence of a New Conserved Domain in CART1, a Novel Member of the Tumor Necrosis Factor Receptor-associated Protein Family, Which Is Expressed in Breast Carcinoma
46. Genetic Resistance to JAK2 Enzymatic Inhibitors Is Overcome by HSP90 Inhibition
47. Expression pattern of human hair keratin basic 1 (hHb1) in hair follicle and pilomatricoma.
48. Comparative expression of the psoriasin ( S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22.
49. Novel, Potent and Selective JAK2 Inhibitors.
50. Protective or aggressive: Paradoxical role of C3 in atypical hemolytic uremic syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.